Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients.
Gajewski JL, Nimer S, Saliba RM, Thomas M, Przepiorka D, Giralt S, von Besien K, Mehra R, Andersson B, Chan KW, Ippoliti C, Warkinten D, Feigs S, Territo M, Schiller G, Lebkowski J, Moseley AM, Lloyd K, von Hoeff M, Okarma T, Champlin R.
Gajewski JL, et al. Among authors: nimer s.
Cytotherapy. 1999;1(5):401-7. doi: 10.1080/0032472031000141284.
Cytotherapy. 1999.
PMID: 20426540
Clinical Trial.